Evaluating Out-of-Hospital 30-Day Mortality After Transfemoral Transcatheter Aortic Valve Replacement
Authors:
- 1 February 2021
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 14 (3) , 261-274
Abstract
No abstract availableKeywords
Funding Information
- Servier
- Novartis
This publication has 19 references indexed in Scilit:
- Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic StenosisJACC, 2019
- Prognostic value of late gadolinium enhancement on CMR in patients with severe aortic valve disease: a systematic review and meta-analysisClinical Radiology, 2018
- Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected PopulationJAMA Cardiology, 2017
- 2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryJACC, 2017
- Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2016
- Analysis of Early Out-of Hospital Mortality After Transcatheter Aortic Valve Implantation Among Patients With Aortic Stenosis Successfully Discharged from the Hospital and Alive at 30 Days (from the Placement of Aortic Transcatheter Valves Trial)The American Journal of Cardiology, 2014
- Prognostic Significance of LGE by CMR in Aortic Stenosis Patients Undergoing Valve ReplacementJACC, 2014
- The STS-ACC Transcatheter Valve Therapy National RegistryJACC, 2013
- Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve ImplantationJACC, 2012
- Health Status Identifies Heart Failure Outpatients at Risk for Hospitalization or DeathJACC, 2006